Launch week offerEnds in00h00m00s

annual Promonthly Pro

Rossana Roncato

Associate Professor of Pharmacology

University of Udine

Italy

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Italy

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Collaborators (15)

Fabio Puglisi

Head of the Unit of Medical Oncology and Cancer Prevention

ITALY

View details

Francesca Gay

Associate Professor

University of Turin

ITALY

View details

federica sangiuolo

Associate professor

Università degli Studi di Roma La Sapienza

ITALY

View details

Luca Gallelli

Prof

Magna Graecia University

ITALY

View details

Matteo Floris

Docenti di ruolo di IIa fascia

University of Cagliari

ITALY

View details

Yitian Zhou

Assistant Professor

Karolinska Institutet

SWEDEN

View details

Alessandro Gozzetti

Docenti di ruolo di IIa fascia

University of Siena

ITALY

View details

Heshu Abdullah-Koolmees

Utrecht University

NETHERLANDS

View details

Claudia Pisanu

Associate Professor

University of Cagliari

ITALY

View details

Niccolò Bolli

Associate Professor

University of Milan

ITALY

View details

Matthias Samwald

Medical University of Vienna

AUSTRIA

View details

Matthias Schwab

GERMANY

View details

Henk-Jan Guchelaar

Leiden University Medical Center

NETHERLANDS

View details

Ivan Krecak

CROATIA

View details

Gabriele Buda

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Rossana Roncato

Research Interests

Make your next move.

Explore related searches

Articles (20)

Pharmacogenetic testing in Italy: results of a nationwide survey by the Joint Working Group for the pharmacogenetics implementation in Italy

Chronotherapy in Hematological Malignancies: Evaluating the Rationale and Evidence

Refining the role of selinexor in multiple myeloma: strategic use in a shifting treatment landscape

Editorial: Innovations in pharmacogenomics: embracing diversity and clinical application

Multinational cost-utility analysis of panel-based pharmacogenetics-guided treatment of patients enrolled in the U-PGx PREPARE study

A systematic literature review of economic evaluations of setmelanotide

Beyond Conventional Monoclonals: Novel Antibody Formats and Derivatives as the Next Frontier in Cancer Therapy

DPYD and UGT1A1 Genotype‐Based Dosing for Fluoropyrimidines and Irinotecan Chemotherapy: Variant‐Specific Impact on Treatment Intensity and Toxicity

DPYD c.85 T > C, DPYD c.496 A>G, and DPYD c.2194 G>A and severe toxicity to fluoropyrimidines in PREPARE and Alpe-DPD trials. An original study and meta-analysis

Pharmacogenetic Implementation Studies—Lessons Learned From the PREPARE Study

Integration of germline pharmacogenomic burden to predict fluoropyrimidine-related toxicity – A secondary analysis of the PREPARE trial

Treatment-Resistant Depression: Esketamine Is Promising, but Personalized Medicine Including Pharmacogenetic Testing Should Come First

Clinical relevance and methodological approach for the assessment of drug–drug interactions in cancer patients: a position statement from the Italian Association of Medical Oncology (AIOM) and the Italian Society of Pharmacology (SIF)

Pharmacokinetics of therapies approved for spinal muscular atrophy: A narrative review of current evidence

Uptake of DPYD and UGT1A1 testing in Italy and adherence to pharmacogenetic guidelines: A 5-year perspective from an EQA provider

mHealth Apps Available in Italy to Support Health Care Professionals in Antimicrobial Stewardship Implementation: Systematic Search in App Stores and Content Analysis

Quantification of Letrozole, Palbociclib, Ribociclib, Abemaciclib, and Metabolites in Volumetric Dried Blood Spots: Development and Validation of an LC-MS/MS Method for Therapeutic Drug Monitoring

Is ctDNA ready to outpace imaging in monitoring early and advanced breast cancer?

Unlocking the potential of Molecular Tumor Boards: from cutting-edge data interpretation to innovative clinical pathways

Therapeutic Monitoring of Palbociclib, Ribociclib, Abemaciclib, M2, M20, and Letrozole in Human Plasma: A Novel LC-MS/MS Method

Collaborators (15)

Fabio Puglisi

Francesca Gay

federica sangiuolo

Luca Gallelli

Matteo Floris

Yitian Zhou

Alessandro Gozzetti

Heshu Abdullah-Koolmees

Claudia Pisanu

Niccolò Bolli

Matthias Samwald

Matthias Schwab

Henk-Jan Guchelaar

Ivan Krecak

Gabriele Buda

Make your next move.

DPYD c.85 T > C, DPYD c.496 A>G, and DPYD c.2194 G>A and severe toxicity to fluoropyrimidines in PREPARE and Alpe-DPD trials. An original study and meta-analysis